We make growth stage investments throughout the United States and look for category-defining companies with visionary leaders that are beginning to scale.
I am currently CEO of Agman, an investment firm with interests in private equity, venture capital, public equity and real estate. I was previously a VC at Atlas Venture.
Highlighted venture investments include: Nasdaq ACAD ($5 billion USD mkt cap); Stromedix (acquired by BiogenIdec for up to $562.5 million); PowderMed (acquired by Pfizer - undisclosed).
- We intend to syndicate every deal possible
- We work closely with companies to add value
- We invest substantial capital in each investment and will always be largest investor
- We ensure terms are fair and syndicated company valuations are reasonable
- Feel free to opt out with no repercussions.